These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12154207)

  • 21. Leflunomide in the treatment of rheumatoid arthritis.
    Li EK; Tam LS; Tomlinson B
    Clin Ther; 2004 Apr; 26(4):447-59. PubMed ID: 15189743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
    Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
    J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
    Schiff MH; Yu EB; Weinblatt ME; Moreland LW; Genovese MC; White B; Singh A; Chon Y; Woolley JM
    Drugs Aging; 2006; 23(2):167-78. PubMed ID: 16536638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
    Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
    Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.
    Fautrel B; Granger B; Combe B; Saraux A; Guillemin F; Le Loet X
    Arthritis Res Ther; 2012 Nov; 14(6):R249. PubMed ID: 23164197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leflunomide versus methotrexate: a comparison of the European and American experience.
    Schiff MH
    Scand J Rheumatol Suppl; 1999; 112():31-5. PubMed ID: 10668525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.
    Proudman SM; James MJ; Spargo LD; Metcalf RG; Sullivan TR; Rischmueller M; Flabouris K; Wechalekar MD; Lee AT; Cleland LG
    Ann Rheum Dis; 2015 Jan; 74(1):89-95. PubMed ID: 24081439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients.
    Ishaq M; Muhammad JS; Hameed K; Mirza AI
    Mod Rheumatol; 2011 Aug; 21(4):375-80. PubMed ID: 21229373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS; Emery P
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S; Gadsby K; Deighton C
    Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
    Aletaha D; Stamm T; Kapral T; Eberl G; Grisar J; Machold KP; Smolen JS
    Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
    Rodriguez-Rodriguez L; Jover-Jover JA; Fontsere O; Peña-Blanco RC; León L; Fernández-Gutierrez B; Abásolo L
    Scand J Rheumatol; 2013; 42(6):433-6. PubMed ID: 23742043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical therapy: where are we now?
    Resman-Targoff BH
    Am J Health Syst Pharm; 2006 Sep; 63(18 Suppl 4):S11-8. PubMed ID: 16960243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T; Amara I; Koch GG
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leflunomide in the treatment of refractory rheumatoid arthritis.
    Kuzmanova SI; Solakov PT; Batalov AZ; Staikova ND; Andreev SA; Russafov PB
    Folia Med (Plovdiv); 2003; 45(3):43-7. PubMed ID: 15366665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.